Infectious Disease
Infectious Disease(传染病)
Infectious Disease 相关产品(1138)
- GC43390DeacetylravidomycinCAS: 88580-27-2纯度: >95.00%
A microbial metabolite with light-dependent antibiotic and anticancer activities
- GC43418Desethylene Ciprofloxacin (hydrochloride)CAS: 528851-31-2纯度: >98.00%
A major metabolite and degradation product of ciprofloxacin
- GC43436DiacetylcercosporinCAS: 62574-06-5纯度: >95.00%
A perylenequinone that has diverse biological activities
- GC43488DL-erythro/threo Sphinganine (d16:0)CAS: 50731-08-3纯度: >98.00%
A mixture of sphingolipid pathway intermediates
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43240 | Chloramphenicol Acetate | 10318-16-8 | >97.00% | |
An acetylated version of chloramphenicol | ||||
| GC43242 | Chloramphenicol Succinate | 3544-94-3 | >99.00% | |
A prodrug form of chloramphenicol | ||||
| GC43244 | Chlorin e6 | 19660-77-6 | >90.00% | |
Chlorin e6(Ce6) 是第二代光敏剂。 | ||||
| GC43274 | Citromycetin | 478-60-4 | >95.00% | |
A fungal metabolite | ||||
| GC43278 | Clindamycin Sulfoxide | 22431-46-5 | >90.00% | |
An active metabolite of clindamycin | ||||
| GC43298 | Colistin | 1066-17-7 | >95.00% | |
An antibiotic | ||||
| GC43314 | Corynecin I | 4423-58-9 | >99.00% | |
A chloramphenicol-like antibiotic | ||||
| GC43340 | Cyclic di-IMP (sodium salt) | - | >95.00% | |
A synthetic second messenger | ||||
| GC43342 | Cyclo(L-Leu-L-Pro) | 2873-36-1 | >99.00% | |
A diketopiperazine metabolite | ||||
| GC43368 | D,L-1′-Acetoxychavicol Acetate | 52946-22-2 | >95.00% | |
A natural exportin 1 inhibitor | ||||
| GC43386 | DDD85646 | 1215010-55-1 | >95.00% / >98.00% | |
DDD85646是一种有效的布氏锥虫N-肉豆蔻酰转移酶（NMT）抑制剂，其对于布氏锥虫N-肉豆蔻酰转移酶（TbNMT）的半数抑制浓度（IC₅₀）为2nM，对于人源N-肉豆蔻酰转移酶（hNMT）的IC₅₀为4nM。 | ||||
| GC43390 | Deacetylravidomycin | 88580-27-2 | >95.00% | |
A microbial metabolite with light-dependent antibiotic and anticancer activities | ||||
| GC43394 | Decatromicin B | 235097-64-0 | >95.00% | |
A bacterial metabolite | ||||
| GC43395 | Deethylindanomycin | 106803-22-9 | >95.00% | |
A polyether antibiotic | ||||
| GC43396 | Defensin HNP-1 (human) (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC43397 | Defensin HNP-2 (human) (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC43398 | Defensin HNP-3 (human) (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC43408 | Deoxycholic Acid (sodium salt hydrate) | 145224-92-6 | >95.00% | |
A secondary bile acid | ||||
| GC43417 | Desertomycin A | 121820-50-6 | >95.00% | |
A fungal metabolite | ||||
| GC43418 | Desethylene Ciprofloxacin (hydrochloride) | 528851-31-2 | >98.00% | |
A major metabolite and degradation product of ciprofloxacin | ||||
| GC43424 | Desotamide | 194660-14-5 | >95.00% | |
An antibiotic | ||||
| GC43436 | Diacetylcercosporin | 62574-06-5 | >95.00% | |
A perylenequinone that has diverse biological activities | ||||
| GC43467 | Dimethyldioctadecylammonium (bromide) | 3700-67-2 | >95.00% | |
A cationic amphipathic lipid | ||||
| GC43488 | DL-erythro/threo Sphinganine (d16:0) | 50731-08-3 | >98.00% | |
A mixture of sphingolipid pathway intermediates | ||||